 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
INSITE VISION INC, (ISV) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
InSite Vision Incorporated engages in the development of genetically-based technology for the diagnosis, prognosis, and management of glaucoma, as well as ophthalmic pharmaceutical products based on its proprietary DuraSite eyedrop-based drug delivery technology. In addition, it has a retinal program that includes both a therapeutic agent and a retinal drug delivery technology. The company focuses its research and development, and commercial efforts on ISV-403, a DuraSite formulation of fluoroquinolone; ISV-401, a DuraSite formulation of azithromycin, an antibiotic; and OcuGene glaucoma genetic test based on its ISV-900 technology. The company has collaborative agreements with Bausch and Lomb Incorporated; CIBA Vision Ophthalmics; SSP Co., Ltd.; Global Damon Pharm and Kukje Pharma Ind. Co., Ltd.; Columbia Laboratories, Inc.; and Societa Industria Farmaceutica Italiana. InSite Vision is based in Alameda, California.
|
INSITE VISION INC Related |
|
InSite Vision Ophthalmic product development company focusing on genetic research for the diagnosis and treatment of glaucoma and the Durasite eyedrop-based drug delivery system.
|
|
ISV: Profile for INSITE VISION INC - Yahoo! Finance See the company profile for INSITE VISION INC (ISV) including business summary, industry/sector information, number of employees, business summary, corporate ...
|
|
ISV: Summary for INSITE VISION INC - Yahoo! Finance Get detailed information on INSITE VISION INC (ISV) including quote performance, ... INSITE VISION INC Files SEC form 10-Q, Quarterly Report EDGAR Online(Fri, Nov 7) ...
|
|
|
|
|
